Sucralfate Oral Suspension
Product Images NDC 68462-827

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sucralfate Oral Suspension (NDC 68462-827). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Btl (Btl)

Btl (Btl)
Sucralfate Oral Suspension 1 g/10 mL label for oral administration, containing 420 mL. The label includes instructions to shake well before using and avoid freezing. It is distributed by Glenmark Pharmaceuticals Inc., USA. The label displays NDC 68462-827-61 and a barcode, with storage instructions and contact information for Glenmark.*
FDA Label Image
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of sucralfate showing its polysaccharide complex with aluminum hydroxide and water components, including variable x and y values representing the polymerization degree and hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.